Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 114.30
-0.60 (-0.52%)
At close: Jul 6, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 26.4 billion as of July 6, 2026. Its market cap has increased by 2.05% in one year.
Market Cap
26.40B
Enterprise Value
35.44B
Revenue
15.57B
Ranking
n/a
PE Ratio
18.12
Stock Price
114.30
Market Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 26.40B, an increase of 32.47%. That is a compound annual growth rate of 1.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 26.40B | 9.27% |
| Dec 30, 2025 | 24.16B | -23.03% |
| Dec 30, 2024 | 31.39B | -44.53% |
| Dec 28, 2023 | 56.60B | -14.34% |
| Dec 29, 2022 | 66.07B | 17.50% |
| Dec 30, 2021 | 56.23B | 210.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 198.21B |
| Beximco Pharmaceuticals PLC. | 66.92B |
| Renata | 53.17B |
| Unilever Consumer Care | 39.85B |
| The ACME Laboratories | 17.82B |
| Asiatic Laboratories | 17.10B |
| The IBN SINA Pharmaceutical Industry | 10.04B |
| Navana Pharmaceuticals | 7.84B |